← Back to headlines
Takeda Pharmaceutical Stock Positioned for Growth After Strong LATITUDE Atlas Study Data
Takeda Pharmaceutical Company Limited (TAK) stock is being evaluated for growth potential following the release of strong data from its LATITUDE Atlas Study.
30 Jun, 13:10 — 30 Jun, 13:10
Sources
Showing 1 of 1 sources
